Merck Research Laboratories

Find the latest for Merck Research Laboratories company news

Building mycotoxin-resilient supply chains with AI

Mycotoxins have long been a pervasive challenge in agriculture and food production, threatening both animal and human health. As naturally occurring

Secure AI Collaboration Will Fine-Tune OpenFold3 with Proprietary Data

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

Former Pfizer chief scientist joins Immunai's board of directors

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the appointment of Dr. Mikael Dolsten to its board of directors.

Healthcare 6month
Machine Learning Transforms Multicancer Detection Tests

This review discusses the current state of multicancer early detection tests, the role of machine learning in their development, and their implications for oncology practice and patient care.

An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to testify next week.

Johnson & Johnson signed a multibillion-dollar contract with ChemImage in 2019. The two companies will face off in court next week.

How pharmaceutical companies are training their workers on AI

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

Telescope advances self-driving lab technology

Telescope Innovations Corp. (CSE:TELI) is leveraging its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals ・Telescope's Self-Driving Labs (SDLs) integrate AI,

PathAssist Derm Launches on AISight®: Advancing Dermatopathology Research Workflows using AI

Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, accelerating skin cancer research BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- PathAI,